Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1701957
PUBLISHER: IMARC | PRODUCT CODE: 1701957
Contraceptive Drugs Market Report by Product, Age Group, Distribution Channel, and Region 2025-2033
PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global contraceptive drugs market size reached USD 16.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.64% during 2025-2033.
Contraceptive drugs refer to birth control medications that are used to prevent pregnancy and control the birth rate. They are synthetically formulated using two female hormones, namely estrogen and progestin, which prevent ovulation. These hormones also thicken cervical mucus or alter the womb lining to prohibit the entrance of sperm into the cervix for fertilization and implantation. Contraceptive drugs assist in lowering the risks of acne, bone thinning, ovarian cancer, infections in the fallopian tubes and uterus, and premenstrual syndrome (PMS). As a result, they are administered by healthcare practitioners to inhibit unwanted pregnancy amongst women of childbearing age. At present, they are mainly available in oral, injectable, and topical formulations.
Contraceptive Drugs Market Trends:
One of the key factors driving the global contraceptive drugs market is the rising consumer consciousness regarding family planning, the increasing population, and the rising instances of unintended pregnancies. In line with this, the shifting inclination of healthcare practitioners toward modern contraceptive methods over conventional procedures, owing to their multiple benefits, including optimal safety, and better clinical outcomes, are acting as another growth-inducing factor. Additionally, the frequent approvals of novel medications by several regulatory bodies, such as the food and drug administration (FDA), are supporting the market growth. Moreover, the advent of gelatin capsules and non-hormonal vaginal gels that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is impelling the market growth. Apart from this, continuous research and development (R&D) activities and the favorable initiatives undertaken by non-governmental organizations (NGOs) and health agencies to sensitize consumers about contraception techniques, women's health, and sexual wellness are positively augmenting the market growth.
Key Market Segmentation:
Breakup by Product:
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
Breakup by Age Group:
- 15-24 years
- 25-34 years
- 35-44 years
- Above 44 years
Breakup by Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- Clinics
- Online Channel
- Public Channel and NGOs
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Afaxys Inc., Agile Therapeutics, Amneal Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Mithra Pharmaceuticals SA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Viatris Inc.
Key Questions Answered in This Report
- 1.What was the size of the global contraceptive drugs market in 2024?
- 2.What is the expected growth rate of the global contraceptive drugs market during 2025-2033?
- 3.What are the key factors driving the global contraceptive drugs market?
- 4.What has been the impact of COVID-19 on the global contraceptive drugs market?
- 5.What is the breakup of the global contraceptive drugs market based on the product?
- 6.What is the breakup of the global contraceptive drugs market based on the age group?
- 7.What is the breakup of the global contraceptive drugs market based on the distribution channel?
- 8.What are the key regions in the global contraceptive drugs market?
- 9.Who are the key players/companies in the global contraceptive drugs market?
Product Code: SR112025A6300
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Contraceptive Drugs Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Oral Contraceptive Pills
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Injectable Contraceptives
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Topical Contraceptives
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Age Group
- 7.1 15-24 years
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 25-34 years
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 35-44 years
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Above 44 years
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Retail Pharmacy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Hospital Pharmacy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Clinics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Online Channel
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Public Channel and NGOs
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 AbbVie Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Afaxys Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Agile Therapeutics
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 Amneal Pharmaceuticals Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 Bayer AG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Johnson & Johnson
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Mithra Pharmaceuticals SA
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.8 Novartis AG
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Pfizer Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Teva Pharmaceutical Industries Ltd.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Viatris Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.1 AbbVie Inc.
Product Code: SR112025A6300
List of Figures
- Figure 1: Global: Contraceptive Drugs Market: Major Drivers and Challenges
- Figure 2: Global: Contraceptive Drugs Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Contraceptive Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Contraceptive Drugs Market: Breakup by Product (in %), 2024
- Figure 5: Global: Contraceptive Drugs Market: Breakup by Age Group (in %), 2024
- Figure 6: Global: Contraceptive Drugs Market: Breakup by Distribution Channel (in %), 2024
- Figure 7: Global: Contraceptive Drugs Market: Breakup by Region (in %), 2024
- Figure 8: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Contraceptive Drugs (Injectable Contraceptives) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Contraceptive Drugs (Injectable Contraceptives) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Contraceptive Drugs (Topical Contraceptives) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Contraceptive Drugs (Topical Contraceptives) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Contraceptive Drugs (15-24 years) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Contraceptive Drugs (15-24 years) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Contraceptive Drugs (25-34 years) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Contraceptive Drugs (25-34 years) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Contraceptive Drugs (35-44 years) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Contraceptive Drugs (35-44 years) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Contraceptive Drugs (Above 44 years) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Contraceptive Drugs (Above 44 years) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Contraceptive Drugs (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Contraceptive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Contraceptive Drugs (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Contraceptive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Contraceptive Drugs (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Contraceptive Drugs (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Contraceptive Drugs (Online Channel) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Contraceptive Drugs (Online Channel) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Global: Contraceptive Drugs (Public Channel and NGOs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Global: Contraceptive Drugs (Public Channel and NGOs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Global: Contraceptive Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Global: Contraceptive Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: North America: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: North America: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: United States: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: United States: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Canada: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Canada: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: Asia-Pacific: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: Asia-Pacific: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: China: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: China: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Japan: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Japan: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: India: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: India: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: South Korea: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: South Korea: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Australia: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Australia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Indonesia: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Indonesia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Europe: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Europe: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Germany: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Germany: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: France: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: France: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: United Kingdom: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: United Kingdom: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Italy: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Italy: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Spain: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Spain: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Russia: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Russia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Latin America: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Latin America: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Brazil: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Brazil: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Mexico: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Mexico: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 79: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 80: Middle East and Africa: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 81: Middle East and Africa: Contraceptive Drugs Market: Breakup by Country (in %), 2024
- Figure 82: Middle East and Africa: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 83: Global: Contraceptive Drugs Industry: SWOT Analysis
- Figure 84: Global: Contraceptive Drugs Industry: Value Chain Analysis
- Figure 85: Global: Contraceptive Drugs Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Contraceptive Drugs Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Contraceptive Drugs Market Forecast: Breakup by Product (in Million USD), 2025-2033
- Table 3: Global: Contraceptive Drugs Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
- Table 4: Global: Contraceptive Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 5: Global: Contraceptive Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Contraceptive Drugs Market: Competitive Structure
- Table 7: Global: Contraceptive Drugs Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.